Advances in the Treatment of Severe Eosinophilic Asthma

PROGRAM DESCRIPTION This webcast is intended to improve care of patients with severe eosinophilic asthma by accelerating adoption of new recommendations and evidence-based practice change. In-depth discussion of novel agents ...

PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with severe eosinophilic asthma by accelerating adoption of new recommendations and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Assess eosinophils as phenotypic biomarker and its relation to exacerbations, decline in lung function and eosinophilic asthma controlApply emerging anti-interleukin-5 and interleukin-5Rα based therapies in patients with severe eosinophilic asthma

---

Write the first review

Resource tags